Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Chemotherapy and Cutaneous Drug Reactions
- Cetuximab-Associated Elongation of the Eyelashes
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous drug reactions
- Diet in dermatology: Revisited
- Malignant epithelial tumors: Part II. Therapy and prevention
- Drug-Induced Hair Changes
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Environmental Air Pollutants Affecting Skin Functions with Systemic Implications
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Poster Presentations
- Index
- Hypertrichosis of the pinnae in a patient using panitumumab
- Acne and Systemic Disease
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)